News for Healthier Living
Reducing Dose of Popular Blood Thinners May Limit Risk of Future Bleeding
For people taking popular blood thinners rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis) after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests.
December 19, 2024
December 21 2024December 20 2024December 19 2024December 18 2024December 17 2024December 16 2024December 15 2024December 14 2024December 13 2024December 12 2024December 11 2024December 10 2024December 9 2024December 8 2024December 7 2024
|
|
|
|
|